Tenet Healthcare Corp (THC) Stock Price & Analysis
Tenet Healthcare Corp (THC) rose 17.17% to USD 233.2 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.
THC last closed at USD 199.02; the session ranged USD 229.37–246.82 on volume of 4,316,007 shares. Market capitalization is $20.09B, with a 52-week range of USD 146.6–247.21 (NYQ). Source: Nexqual, July 25, 2026 at 01:46 UTC.
Key Statistics (as of July 25, 2026 at 01:46 UTC)
| Price | USD 233.2 |
|---|---|
| Change | ▲ 17.17% (up) |
| Previous Close | USD 199.02 |
| Open | USD 235.01 |
| Day Range | USD 229.37 – 246.82 |
| 52-Week Range | USD 146.6 – 247.21 |
| Volume | 4,316,007 shares |
| Market Cap | $20.09B |
| Exchange | NYQ |
Technical Analysis (THC)
Nexqual's technical model rates THC "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 75.71 (overbought) |
| vs SMA50 | Above (USD 185.96) |
| MACD | 6.14 (positive) |
Analyst Ratings (THC)
Wall Street analysts rate THC "Strong Buy" based on 21 analysts, with a mean price target of USD 249.9 (range USD 210–290), per Nexqual as of July 25, 2026 at 01:46 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 249.9 |
| High Target | USD 290 |
| Low Target | USD 210 |
| Buy / Hold / Sell | 20 / 2 / 0 |
Earnings (THC)
| Next Earnings Date | 2026-07-23 |
|---|---|
| EPS Estimate | USD 4.24 |
| Revenue Estimate | $5.46B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 6.12 vs est 4.26 ▲ beat |
| 2026-03-31 | USD 4.82 vs est 4.17 ▲ beat |
| 2025-12-31 | USD 4.7 vs est 4.07 ▲ beat |
| 2025-09-30 | USD 3.7 vs est 3.35 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Financials & Fundamentals (THC)
| Total Revenue | $22.64B |
|---|---|
| Revenue Growth (YoY) | +15.80% |
| Gross Margin | +43.79% |
| Operating Margin | +24.60% |
| Profit Margin | +9.90% |
| ROE | +37.34% |
| Debt / Equity | 152.28 |
| Current Ratio | 1.41 |
| Total Cash | $2.17B |
| Total Debt | $13.25B |
| Free Cash Flow | $2.72B |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Financial Health Score (THC)
Nexqual rates Tenet Healthcare Corp's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:46 UTC.
| Growth | Mixed — Revenue +3.1% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 25% |
| Balance Sheet | Weak — $2.17B cash vs $13.2B debt |
| Cash Flow | Solid — FCF $2.72B, 13% margin |
| Efficiency | Strong — ROE 37%, ROA 10.0% |
Ownership (THC)
| Insider Ownership | +1.10% |
|---|---|
| Institutional Ownership | +98.14% |
| Shares Outstanding | 86.14M |
| Float | 82.54M |
| Short % of Float | +5.03% |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Leadership (THC)
Tenet Healthcare Corp is led by Saumya Sutaria (age 52), Chairman & CEO, per Nexqual as of July 25, 2026 at 01:46 UTC.
| Chairman & CEO | Saumya Sutaria (age 52) |
|---|---|
| Executive VP & CFO | Sun K. Park (age 49) |
| Executive VP & Chief Operating Officer | Lisa Y. Foo (age 34) |
| Vice President of Investor Relations | William McDowell |
| Executive Vice President of Corporate Development | Michael T. Maloney |
Major Backers & Investors (THC)
Notable institutional backers of Tenet Healthcare Corp include Price (T.Rowe) Associates Inc, FMR, LLC, Boston Partners, according to Nexqual as of July 25, 2026 at 01:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 11.91% |
| FMR, LLC | 9.03% |
| Boston Partners | 4.45% |
| Wellington Management | 2.72% |
| Lone Pine Capital | 2.62% |
| T. Rowe Price | 2.35% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 17.71% |
| BlackRock | 13.57% |
| State Street | 3.92% |
| Geode Capital | 2.24% |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
From Tenet Healthcare Corp's Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- We have developed an expansive set of policies and procedures in our efforts to comply with HIPAA, and similar state privacy laws, under the guidance of our ethics and compliance department.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCA | HCA Healthcare, Inc. | USD 382.19 | ▲ 2.78% |
| UHS | Universal Health Services, Inc. | USD 155.75 | ▲ 4.29% |
| CYH | Community Health Systems, Inc. | USD 2.73 | ▼ 15.22% |
| HUM | Humana Inc. | USD 389.32 | ▼ 2.08% |
| CI | The Cigna Group | USD 289.57 | ▲ 1.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.